0000950170-25-038107 | 10-K | XBRL Viewer

Print Document

INCOME TAX EXPENSE - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards, Limitations on Use	The NOL carryforwards begin to expire in 2032 and may become subject to annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50%, as defined under I.R.C. Section 382
Operating Loss Carry forwards Percentage	50.00%
Federal [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$ 279.8
State [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$ 239.0

Property and Equipment, Net - Summary of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Computer equipment and software	$ 7,382	$ 1,202
Less accumulated depreciation	$ (1,123)	$ (888)

Consolidated Statements Of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net Income (Loss)	$ 1,148	$ (19,182)	$ (79,672)
Other comprehensive income:
Change in unrealized gains on marketable debt securities	2	0	0
Total other comprehensive income	2	0	0
Total comprehensive income (loss)	$ 1,150	$ (19,182)	$ (79,672)

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

- Definition

Amount before tax, after reclassification adjustments of other comprehensive income (loss).

+ References + Details

Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2024

Accrued Expenses and Other Current Liabilities Abstract

Accrued Expenses and Other Current Liabilities

NOTE 7. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities is comprised of the following:


	As of December 31,
(in thousands)	2024		2023
Employee compensation	$	5,144	$	7,269
Professional fees		912		626
Severance		494		—
User acquisition		248		1,525
Other		1,233		3,048
Accrued expenses and other current liabilities	$	8,031	$	12,468

INCOME TAX EXPENSE (Tables)

12 Months Ended

Dec. 31, 2024

Income Tax Disclosure [Abstract]

Summary of Reconciliation of Effective Tax Rate and Statutory Income Tax Rate

A reconciliation of the Company’s statutory income tax rate to the Company’s effective income tax rate is as follows:


	Year Ended December 31,
(in thousands)	2024			2023			2022
Income (loss) before income taxes	$	1,242		$	(18,964	)	$	(79,418	)
Statutory tax rate		21	%		21	%		21	%
Federal taxes		261			(3,982	)		(16,678	)
Increase (decrease) in effective tax rate due to:
State taxes, net of federal benefit		(164	)		276			(4,079	)
Impairment of goodwill		—			—			1,288
Permanent differences		683			897			83
Other Adjustments		(648	)		(373	)		(6,669	)
Valuation allowance		(38	)		3,400			26,309
Actual income taxes	$	94		$	218		$	254

Summary of Income Before Income Taxes

Income (loss) before taxes is attributable to the following tax jurisdictions:


	Year Ended December 31,
(in thousands)	2024		2023			2022
U.S. operations	$	1,078	$	(19,576	)	$	(79,788	)
Foreign operations		164		612			370
Income (loss) before income taxes	$	1,242	$	(18,964	)	$	(79,418	)

Summary of Deferred Tax Assets

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:


	As of December 31,
(in thousands)	2024			2023
Net deferred tax assets:
Net operating loss carryforwards	$	70,373		$	70,701
Stock based compensation		3,338			2,892
Depreciation		232			378
Other		201			45
Total gross deferred tax assets, net		74,144			74,016
Valuation allowance		(73,978	)		(74,016	)
Deferred tax liabilities (long term):
Other		(166	)		—
Net deferred tax assets	$	—		$	—

Summary of income tax expense (benefit)

Income taxes are comprised of the following:


	Year Ended December 31,
(in thousands)	2024			2023		2022
Current:
Federal	$	—		$	—	$	—
State		169			44		40
Foreign		46			174		214
Total Current		215			218		254
Deferred:
Federal		—			—		—
State		(121	)		—		—
Foreign		—			—		—
Total Deferred		(121	)		—		—
Total	$	94		$	218	$	254

Summary of Significant Accounting Policies and Estimates - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) Age	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Cash equivalents, Maturity terms	3 months
Goodwill impairment charge	$ 0	$ 0	$ 6,134
Provision for uncertain tax positions	0	0
Accrued interest or penalties	0	0
Advertising expense	$ 26,100	$ 25,200	$ 37,800
Eligible age \| Age	21
Eligible employee's contribution	100.00%
Maximum
Eligible earnings	4.00%
Computers and software
Average useful life of fixed assets	3 years

Intangible Assets, Net - Summary of Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Intangible assets with finite lives:
Less: accumulated amortization	$ (1,862)	$ (1,415)
Intangible assets, net	1,339	1,786
Acquired technology [Member]
Intangible assets with finite lives:
Acquired technology	$ 3,201	$ 3,201

Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2024

Accrued Expenses and Other Current Liabilities Abstract

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities is comprised of the following:


	As of December 31,
(in thousands)	2024		2023
Employee compensation	$	5,144	$	7,269
Professional fees		912		626
Severance		494		—
User acquisition		248		1,525
Other		1,233		3,048
Accrued expenses and other current liabilities	$	8,031	$	12,468

Commitments and Contingent Liabilities

12 Months Ended

Dec. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingent Liabilities

NOTE 8. COMMITMENTS AND CONTINGENT LIABILITIES

Litigation

The Company may in the future be involved in various legal proceedings, claims and litigation that arise in the normal course of business. The Company accrues for estimated loss contingencies related to legal matters when available information indicates that it is probable a liability has been incurred and the Company can reasonably estimate the amount of that loss. In many proceedings, however, it is inherently difficult to determine whether any loss is probable or even possible or to estimate the amount of any loss. In addition, even where a loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is often not possible to reasonably estimate the size of the possible loss or range of loss or possible additional losses or range of additional losses. As of December 31, 2024, there were no material pending legal proceedings, claims or litigation.

Warranties and Indemnification

The Company’s arrangements generally include certain provisions for indemnifying customers against liabilities if there is a breach of a customer’s data or if the Company’s service infringes a third party’s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnifications.

The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as a director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer liability insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may also be subject to indemnification obligations by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.

STOCK-BASED COMPENSATION - Summary of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock based compensation expense	$ 9,173	$ 8,395	$ 12,116
Research and development, net
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock based compensation expense	1,781	2,463	2,550
Clinical Operations
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock based compensation expense	293	455	549
Sales and Marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock based compensation expense	1,860	1,722	3,090
General and administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock based compensation expense	$ 5,239	$ 3,755	$ 5,927

Variable Interest Entities (Tables)

12 Months Ended

Dec. 31, 2024

VariableInterestEntityDisclosureAbstract

Assets and liabilities of the Company's consolidated VIE

The following table details the assets and liabilities of the VIEs as of December 31, 2024 and 2023. The assets and liabilities in the table below are presented prior to consolidation and thus a portion of these assets and liabilities are eliminated in consolidation.


(in thousands)	December 31, 2024		December 31, 2023
ASSETS
Cash and cash equivalents	$	132	$	167
Accounts receivable		6,743		4,031
Other assets		20,986		11,493
Total Assets	$	27,861	$	15,691
LIABILITIES
Accrued expenses and other current liabilities		2,528		2,831
Total Liabilities	$	2,528	$	2,831

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

INCOME TAX EXPENSE

12 Months Ended

Dec. 31, 2024

Income Tax Disclosure [Abstract]

Income Tax

NOTE 12. INCOME TAX EXPENSE

The Company and its subsidiaries file income tax returns in the U.S. federal, and various states and foreign jurisdictions. The Company assessed its uncertain tax positions and determined that it has no uncertain tax positions at December 31, 2024.

A reconciliation of the Company’s statutory income tax rate to the Company’s effective income tax rate is as follows:


	Year Ended December 31,
(in thousands)	2024			2023			2022
Income (loss) before income taxes	$	1,242		$	(18,964	)	$	(79,418	)
Statutory tax rate		21	%		21	%		21	%
Federal taxes		261			(3,982	)		(16,678	)
Increase (decrease) in effective tax rate due to:
State taxes, net of federal benefit		(164	)		276			(4,079	)
Impairment of goodwill		—			—			1,288
Permanent differences		683			897			83
Other Adjustments		(648	)		(373	)		(6,669	)
Valuation allowance		(38	)		3,400			26,309
Actual income taxes	$	94		$	218		$	254

The main reconciling item between the statutory tax rate of the Company and the effective tax rate is the recognition of valuation allowance in respect of deferred taxes relating to accumulated net operating losses carried forward due to the uncertainty of the realization of such deferred taxes.

Income (loss) before taxes is attributable to the following tax jurisdictions:


	Year Ended December 31,
(in thousands)	2024		2023			2022
U.S. operations	$	1,078	$	(19,576	)	$	(79,788	)
Foreign operations		164		612			370
Income (loss) before income taxes	$	1,242	$	(18,964	)	$	(79,418	)

Income taxes are comprised of the following:


	Year Ended December 31,
(in thousands)	2024			2023		2022
Current:
Federal	$	—		$	—	$	—
State		169			44		40
Foreign		46			174		214
Total Current		215			218		254
Deferred:
Federal		—			—		—
State		(121	)		—		—
Foreign		—			—		—
Total Deferred		(121	)		—		—
Total	$	94		$	218	$	254

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:


	As of December 31,
(in thousands)	2024			2023
Net deferred tax assets:
Net operating loss carryforwards	$	70,373		$	70,701
Stock based compensation		3,338			2,892
Depreciation		232			378
Other		201			45
Total gross deferred tax assets, net		74,144			74,016
Valuation allowance		(73,978	)		(74,016	)
Deferred tax liabilities (long term):
Other		(166	)		—
Net deferred tax assets	$	—		$	—

Realization of the future tax benefits is dependent on the Company’s ability to generate sufficient taxable income within the carryforward period. A valuation allowance is provided for deferred tax assets when it is “more likely than not” that some portion of the deferred tax asset will not be realized. Because of the Company’s recent history of operating losses, management believes the recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not more likely than not to be realized and, accordingly, has provided a full valuation allowance. A valuation allowance has been recorded for the net deferred tax assets at December 31, 2024 and 2023.

The Company maintains a full valuation allowance on its net deferred tax assets. The assessment regarding whether a valuation allowance is required considers both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. In making this assessment, significant weight is given to evidence that can be objectively verified. Management considered the Company’s cumulative loss in recent years as significant negative evidence. Based upon a review of the four sources of income identified within ASC 740, management determined that the negative evidence outweighed the positive evidence and that a full valuation allowance on the net deferred tax assets will be maintained. Management will continue to assess the realizability of our deferred tax assets going forward and will adjust the valuation allowance as needed. The Company’s valuation allowance decrease was immaterial for the year ended December 31, 2024; the decrease was primarily due to decreases in its net operating loss carryforwards.

At December 31, 2024, the Company has federal and state net operating loss carryovers (“NOL”) of approximately $279.8 million and $239.0 million, respectively, which are available to reduce future taxable income. The NOL carryforwards begin to expire in 2032 and may become subject to annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50%, as defined under I.R.C. Section 382.

This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or future tax liabilities. The federal losses generated from 2018 onward do not expire.

The Company is subject to U.S. federal and state and Israeli income taxes with varying statutes of limitations. The Company is not currently under examination by any income tax authority, nor has it been notified that an examination is contemplated. The Company is no longer subject to U.S. federal, state or local income tax examinations by the tax authorities for years before 2019. The Israel subsidiary tax assessments filed by the Company through the year 2019 are considered closed.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

Description of Organization and Business Operations

12 Months Ended

Dec. 31, 2024

Description Of Organisation And Business Operation [Abstract]

Description Of Organization And Business Operation Disclosure

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Talkspace, Inc. (together with its consolidated subsidiaries, the “Company” or “Talkspace”) is a leading behavioral healthcare company enabled by a purpose-built technology platform. Talkspace provides individuals and licensed therapists, psychologists and psychiatrists with an online platform for one-on-one therapy delivered via messaging, audio and video. The Company offers convenient and affordable access to a fully credentialed network of highly qualified providers. Since its inception, the Company has connected millions of patients with licensed behavioral health providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry.

The Company has three wholly-owned subsidiaries and holds variable interest in one professional association and various professional corporations, which have been established pursuant to the requirements of their respective domestic jurisdiction governing the corporate practice of medicine. These entities are considered Variable Interest Entities (“VIEs”). See Note 13, “Variable Interest Entities,” for further details.

Summary of Significant Accounting Policies and Estimates - Summary Of Depreciation Of Property Plant Equipment (Detail)	Dec. 31, 2024
Computers and software
Schedule Of Depreciation Of Property Plant Equipment [Line Items]
Average useful life of fixed assets	3 years
Furniture and equipment
Schedule Of Depreciation Of Property Plant Equipment [Line Items]
Average useful life of fixed assets	5 years

Insider Trading Policies and Procedures	3 Months Ended
Insider Trading Policies and Procedures	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Intangible Assets, Net - Summary of Future Amortization Expenses (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]
2025	$ 446
2026	446
2027	447
Intangible assets, net	$ 1,339	$ 1,786

Variable Interest Entities - Assets and liabilities of the VIEs (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
ASSETS
Cash and cash equivalents	$ 76,692	$ 123,908
Accounts receivable, net	9,643	10,174
Total assets	138,677	142,221
LIABILITIES
Accrued expenses and other current liabilities	8,031	12,468
Variable Interest Entity [Member]
ASSETS
Cash and cash equivalents	132	167
Accounts receivable, net	6,743	4,031
Other Assets	20,986	11,493
Total assets	27,861	15,691
LIABILITIES
Accrued expenses and other current liabilities	2,528	2,831
Total Liabilities	$ 2,528	$ 2,831

- Definition

Amount of asset recognized for present right to economic benefit.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481203/810-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481231/810-10-45-25

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481404/852-10-50-7

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

+ Details

STOCK-BASED COMPENSATION - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation cost, non-vested options	$ 2,300
Unrecognized compensation cost non-vested options to be recognized, period	1 year
Stock based compensation expense	$ 9,173	$ 8,395	$ 12,116
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value	$ 2.87
Unrecognized compensation cost, non-vested options	$ 11,100
Unrecognized compensation cost non-vested options to be recognized, period	1 year 6 months
Share-based compensation, vesting period	4 years
Fair value of RSUs vested	$ 10,400	$ 5,000	$ 3,700
Stock based compensation expense	$ 1,200
Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value	$ 1.48	$ 0.74	$ 0.88
Total intrinsic value of stock options exercised	$ 3,000	$ 2,500	$ 4,200

Revenue Recognition

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue Recognition

NOTE 3. REVENUE RECOGNITION

The following table presents the Company’s consolidated revenues from sales to unaffiliated customers disaggregated by revenue source:


	Year Ended December 31,
	2024		2023		2022
(in thousands)
Payor	$	124,339	$	80,823	$	36,168
DTE		38,466		33,614	$	28,241
Consumer		24,788		35,608		55,158
Total	$	187,593	$	150,045	$	119,567

For the year ended December 31, 2024, three customers represented 10% or more of the Company's consolidated revenues and these amounts were approximately $27.6 million, $25.3 million and $22.7 million. For the year ended December 31, 2023 and 2022, two customers represented 10% or more of total revenue.

Accounts Receivable, net

The Company had accounts receivable, net, related to revenue from DTE customers of $6.0 million and $7.8 million at December 31, 2024 and December 31, 2023, respectively. As of December 31, 2024 and 2023, the balance of accounts receivable, net, related to revenue from Payor customers was $3.6 million and $2.4 million, respectively. Credit losses related to these receivables were immaterial for the years ended December 31, 2024, 2023 and 2022.

Deferred Revenues

For the year ended December 31, 2024 and 2023, the Company recognized revenues of $2.0 million and $2.8 million, respectively, that were included in deferred revenues at the beginning of the year. As of December 31, 2024, deferred revenue mainly related to the Company’s Consumer subscription business.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

+ Details

Fair Value Measurements - Schedule of Assets and Liabilities, Recorded at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	$ 117,808	$ 123,908
Unrealized Gains	15	0
Unrealized Losses	(13)	0
Fair Value	117,810	123,908
Cash and cash equivalents	76,692	123,908
Marketable securities	41,118	0
Cash [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	911	1,078
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	911	1,078
Cash and cash equivalents	911	1,078
Marketable securities	0	0
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	75,515
Unrealized Gains	3
Unrealized Losses	0
Fair Value	75,518
Cash and cash equivalents	69,287
Marketable securities	6,231
Fair Value, Inputs, Level 1 [Member] \| Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	68,639	122,830
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	68,639	122,830
Cash and cash equivalents	68,639	122,830
Marketable securities	0	0
Fair Value, Inputs, Level 1 [Member] \| Commercial Paper [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	6,876
Unrealized Gains	3
Unrealized Losses	0
Fair Value	6,879
Cash and cash equivalents	648
Marketable securities	6,231
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	41,382
Unrealized Gains	12
Unrealized Losses	(13)
Fair Value	41,381
Cash and cash equivalents	6,494
Marketable securities	34,887
Fair Value, Inputs, Level 2 [Member] \| US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	7,232
Unrealized Gains	2
Unrealized Losses	0
Fair Value	7,234
Cash and cash equivalents	6,494
Marketable securities	740
Fair Value, Inputs, Level 2 [Member] \| U.S. Government Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	1,439
Unrealized Gains	2
Unrealized Losses	0
Fair Value	1,441
Cash and cash equivalents	0
Marketable securities	1,441
Fair Value, Inputs, Level 2 [Member] \| Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	29,791
Unrealized Gains	7
Unrealized Losses	(13)
Fair Value	29,785
Cash and cash equivalents	0
Marketable securities	29,785
Fair Value, Inputs, Level 2 [Member] \| Certificates of Deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Adjusted Cost Basis	2,920
Unrealized Gains	1
Unrealized Losses	0
Fair Value	2,921
Cash and cash equivalents	0
Marketable securities	2,921
Fair Value, Inputs, Level 3 [Member] \| Private Placement Warrant [Member]
LIABILITIES
Total Warrant Liabilities	$ 1,690	$ 1,842	$ 939

Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders for the years ended December 31, 2024, 2023 and 2022:


	Year Ended December 31,
(in thousands except share and per share data)	2024		2023			2022
Net income (loss)	$	1,148	$	(19,182	)	$	(79,672	)
Weighted-average shares used to compute net income (loss) per share:
Basic		168,906,900		165,039,920			156,885,256
Dilutive effect of share-based awards		7,588,972		—			—
Diluted		176,495,872		165,039,920			156,885,256
Net income (loss) per share:
Basic	$	0.01	$	(0.12	)	$	(0.51	)
Diluted	$	0.01	$	(0.12	)	$	(0.51	)

INCOME TAX EXPENSE - Income taxes are comprised (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current:
Federal	$ 0	$ 0	$ 0
State	169	44	40
Other	46	174	214
Total Current	215	218	254
Deferred:
Federal	0	0	0
State	(121)	0	0
Other	0	0	0
Total Deferred	(121)	0	0
Total	$ 94	$ 218	$ 254

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2024	Dec. 31, 2023
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	168,849,591	168,428,856
Common stock, shares outstanding	168,849,591	168,428,856

Fixed Assets, Net (Tables)

12 Months Ended

Dec. 31, 2024

Fixed Assets Disclosure [Abstract]

Schedule of Fixed assets, Net

Fixed assets, net is included as part of other long-term assets in the consolidated balance sheets. Fixed assets, net as of December 31, 2024 and 2023 consisted of the following:


	December 31, 2024			December 31, 2023
(in thousands)
Capitalized internal-use software costs	$	6,488		$	431
Computers and equipment		755			736
Other		139			35
Total cost		7,382			1,202
Less: accumulated depreciation		(1,123	)		(888	)
Fixed assets, net	$	6,259		$	314

Property and Equipment, Net

12 Months Ended

Dec. 31, 2024

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

NOTE 6. FIXED ASSETS, NET

Fixed assets, net is included as part of other long-term assets in the consolidated balance sheets. Fixed assets, net as of December 31, 2024 and 2023 consisted of the following:


	December 31, 2024			December 31, 2023
(in thousands)
Capitalized internal-use software costs	$	6,488		$	431
Computers and equipment		755			736
Other		139			35
Total cost		7,382			1,202
Less: accumulated depreciation		(1,123	)		(888	)
Fixed assets, net	$	6,259		$	314

As of December 31, 2024, the Company capitalized $6.1 million of qualifying internal-use software development costs, net ($0.2 million as of December 31, 2023). Depreciation and amortization expense related to the Company's fixed assets was immaterial for the years ended December 31, 2024, 2023 and 2022.

Capital Stock

12 Months Ended

Dec. 31, 2024

Stockholders' Equity Note [Abstract]

Capital Stock

NOTE 9. CAPITAL STOCK

The Company’s authorized capital stock consists of (a) 1,000,000,000 shares of common stock, par value $0.0001 per share; and (b) 100,000,000 shares of preferred stock, par value $0.0001 per share. As of December 31, 2024 there were 12,757,500 Private Placement Warrants and 20,722,500 Public Warrants (12,780,000 Private Placement Warrants and 20,700,000 Public Warrants as of December 31, 2023) to purchase the Company’s common stock at an exercise price of $11.50 per share. No shares of preferred stock were issued or outstanding for any years presented.

Share Repurchase Program

On February 22, 2024, the Company announced that its Board of Directors approved a share repurchase program to authorize the repurchase of up to $15.0 million of the currently outstanding shares of the Company’s common stock over a period of twenty-four months beginning on March 1, 2024 (the “Share Repurchase Program”). On August 1, 2024, the Company’s Board of Directors amended the Share Repurchase Program to authorize the Company to repurchase up to an additional $25.0 million

of its common stock. The Share Repurchase Program will remain in effect until the earliest (1) the total authorized dollar amount of shares is repurchased or (2) August 1, 2026.

During the year ended December 31, 2024, the Company repurchased and retired an aggregate of 3,911,259 shares of its common stock for a total consideration of $11.0 million ($2.81 per share). As of December 31, 2024, $29.0 million remained available under the Share Repurchase Program.

Such purchases will be at times and in amounts as the Company deems appropriate, based on factors such as price, market conditions, corporate and regulatory requirements, constraints specified in any Rule 10b5-1 trading plans, alternative investment opportunities and other business considerations. All shares repurchased will be retired. The program does not obligate the Company to repurchase any dollar amount or number of shares, and may be modified, suspended, or discontinued at any time at the Company’s discretion without prior notice.

Fair Value measurement - Summarizes of the remaining contractual maturities of our cash equivalents and marketable securities (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Debt Securities, Available-for-Sale [Line Items]
Due within one year	$ 29,499
Due after one year through two years	11,619
Total	$ 41,118

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aaa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

+ Details

Intangible Assets, Net (Tables)

12 Months Ended

Dec. 31, 2024

Finite-Lived Intangible Assets, Net [Abstract]

Schedule of Finite-Lived Intangible Assets

Intangible assets is comprised of the following:


	As of December 31,
(in thousands)	2024			2023
Intangible asset with finite live:
Acquired technology	$	3,201		$	3,201
Less: accumulated amortization		(1,862	)		(1,415	)
Intangible assets, net	$	1,339		$	1,786

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Future amortization that will be charged to expense over the remaining life of the intangible asset as of December 31, 2024 is as follows:


December 31,	In thousands
2025	$	446
2026		446
2027		447
	$	1,339

INCOME TAX EXPENSE - Summary of Deferred Tax Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Components of Deferred Tax Assets [Abstract]
Net operating loss carryforwards	$ 70,373	$ 70,701
Stock based compensation	3,338	2,892
Depreciation	232	378
Other	201	45
Total gross deferred tax assets, net	74,144	74,016
Valuation allowance	(73,978)	(74,016)
Other	(166)	0
Deferred Tax Assets, Net, Total	$ 0	$ 0

STOCK-BASED COMPENSATION

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Share-Based Compensation

NOTE 10. STOCK-BASED COMPENSATION

The Company may grant cash and equity incentive awards to officers, employees, directors, consultants and service providers in order to attract, motivate and retain talent under the Talkspace’s 2021 Incentive Award Plan (the “2021 Plan”).

All stock-based awards are measured based on the grant date fair value and are recognized on a straight-line basis in the Company’s consolidated statements of income over the requisite service period (generally requiring a four-year vesting period).

Stock Options

Stock options generally vest over a four-year period and are exercisable a maximum period of ten years. A summary of the Company’s stock option activity for the year ended December 31, 2024 is as follows:


	Year Ended December 31, 2024
	Number of options			Weighted average exercise price		Weighted average remaining contractual term (in years)		Aggregate intrinsic value (1) (in thousands)
Outstanding at beginning of year		11,208,571		$	2.77		6.91	$	11,774
Granted		1,013,381		$	2.51
Exercised		(1,710,285	)	$	1.17
Forfeited		(786,572	)	$	3.89
Outstanding at end of year		9,725,095		$	2.93		6.39	$	12,974
Exercisable at end of year		7,565,044		$	3.15		5.86	$	10,148

(1)

The aggregate intrinsic value of options outstanding and options exercisable at end of the year does not include 2,766,728 and 2,519,646, respectively, of stock options that are out of the money.

The weighted average grant-date fair value of stock options granted to employees during the years ended December 31, 2024 was $1.48 per share ($0.74 per share and $0.88 per share for the years ended December 31, 2023 and 2022, respectively).

The total intrinsic value of stock options exercised during the year ended December 31, 2024 was $3.0 million ($2.5 million and $4.2 million for the years ended December 31, 2023 and 2022, respectively).

The fair value for options granted for the years ended December 31, 2024, 2023 and 2022 was estimated on the date of grant using a Black-Scholes-Merton options pricing model with the following weighted average assumptions:


	Year Ended December 31,
	2024	2023	2022
Dividend yield	0%	0%	0%
Expected volatility	60.81% - 61.65%	58.63% - 68.40%	66.80%-86.13%
Risk-free interest rate	3.71%-4.19%	3.70%-4.22%	1.76%-4.11%
Expected term (years)	5.27 - 6.11	5.23 - 6.25	5.07-6.25

As of December 31, 2024, there was $2.3 million of total unrecognized compensation cost related to non-vested stock options that are expected to be recognized over a weighted average period of 1.0 years.

Restricted Stock Units

Restricted Stock Units (“RSUs”) typically vest over a four-year period. The following table summarizes the activity for RSUs for the year ended December 31, 2024:


	Year Ended December 31, 2024
	Number of restricted stock units			Weighted average grant-date fair value
Nonvested at beginning of year		8,984,827		$	1.30
Granted		3,142,300		$	2.87
Vested		(3,776,287	)	$	1.71
Forfeited		(1,323,765	)	$	1.77
Nonvested at end of year		7,027,075		$	1.73

The total fair value of RSUs vested during the year ended December 31, 2024 was $10.4 million ($5.0 million and $3.7 million for the years ended December 31, 2023 and 2022, respectively).

As of December 31, 2024, there was $11.1 million of total unrecognized compensation cost related to non-vested RSUs that are expected to be recognized over a weighted average period of 1.5 years.

The following table sets forth the total share-based compensation expense related to stock options and RSUs included in the respective components of operating expenses in the consolidated statements of income:


	Year Ended December 31,
(in thousands)	2024		2023		2022
Research and development, net	$	1,781	$	2,463	$	2,550
Clinical Operations, net		293		455		549
Sales and Marketing		1,860		1,722		3,090
General and administrative		5,239		3,755		5,927
Total stock-based compensation expense	$	9,173	$	8,395	$	12,116

During the year ended December 31, 2024, the Company modified certain equity awards in connection with certain key executives' separation from the Company and recognized $1.2 million of additional stock-based compensation expense as a result of these modifications.

Revenue Recognition - Schedule of Disaggregation of Revenue by Revenue Source (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues from sales to unaffiliated customers:
Total Revenue	$ 187,593	$ 150,045	$ 119,567
Payor
Revenues from sales to unaffiliated customers:
Total Revenue	124,339	80,823	36,168
DTE
Revenues from sales to unaffiliated customers:
Total Revenue	38,466	33,614	28,241
Consumer
Revenues from sales to unaffiliated customers:
Total Revenue	$ 24,788	$ 35,608	$ 55,158

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Intangible Assets, Net

12 Months Ended

Dec. 31, 2024

Finite-Lived Intangible Assets, Net [Abstract]

Intangible Assets, Net

NOTE 4. INTANGIBLE ASSETS, NET

Intangible assets is comprised of the following:


	As of December 31,
(in thousands)	2024			2023
Intangible asset with finite live:
Acquired technology	$	3,201		$	3,201
Less: accumulated amortization		(1,862	)		(1,415	)
Intangible assets, net	$	1,339		$	1,786

Amortization expense was $0.4 million for the year ended December 31, 2024 ($0.7 million and $0.9 million for the years ended December 31, 2023 and 2022, respectively) and was included in cost of revenues in the Company’s consolidated statements of income for the periods presented.

Future amortization that will be charged to expense over the remaining life of the intangible asset as of December 31, 2024 is as follows:


December 31,	In thousands
2025	$	446
2026		446
2027		447
	$	1,339

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Fixed Assets, Net (Additional Information) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Fixed Assets Disclosure [Abstract]
Capitalized Software Development Costs	$ 6.1	$ 0.2

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 1,148	$ (19,182)	$ (79,672)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

STOCK-BASED COMPENSATION (Table)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Summary of Stock Option Activity Under 2021 Plan

A summary of the Company’s stock option activity for the year ended December 31, 2024 is as follows:


	Year Ended December 31, 2024
	Number of options			Weighted average exercise price		Weighted average remaining contractual term (in years)		Aggregate intrinsic value (1) (in thousands)
Outstanding at beginning of year		11,208,571		$	2.77		6.91	$	11,774
Granted		1,013,381		$	2.51
Exercised		(1,710,285	)	$	1.17
Forfeited		(786,572	)	$	3.89
Outstanding at end of year		9,725,095		$	2.93		6.39	$	12,974
Exercisable at end of year		7,565,044		$	3.15		5.86	$	10,148

(1)

The aggregate intrinsic value of options outstanding and options exercisable at end of the year does not include 2,766,728 and 2,519,646, respectively, of stock options that are out of the money.

Summary of Fair Value of Option Granted Share-based Payment Award Stock Options Valuation Assumptions


	Year Ended December 31,
	2024	2023	2022
Dividend yield	0%	0%	0%
Expected volatility	60.81% - 61.65%	58.63% - 68.40%	66.80%-86.13%
Risk-free interest rate	3.71%-4.19%	3.70%-4.22%	1.76%-4.11%
Expected term (years)	5.27 - 6.11	5.23 - 6.25	5.07-6.25

Summary of Stock Option Activity Under Restricted Stock Units

The following table summarizes the activity for RSUs for the year ended December 31, 2024:


	Year Ended December 31, 2024
	Number of restricted stock units			Weighted average grant-date fair value
Nonvested at beginning of year		8,984,827		$	1.30
Granted		3,142,300		$	2.87
Vested		(3,776,287	)	$	1.71
Forfeited		(1,323,765	)	$	1.77
Nonvested at end of year		7,027,075		$	1.73

Summary of Stock-Based Compensation Expense


	Year Ended December 31,
(in thousands)	2024		2023		2022
Research and development, net	$	1,781	$	2,463	$	2,550
Clinical Operations, net		293		455		549
Sales and Marketing		1,860		1,722		3,090
General and administrative		5,239		3,755		5,927
Total stock-based compensation expense	$	9,173	$	8,395	$	12,116

Variable Interest Entities

12 Months Ended

Dec. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Variable Interest Entity Disclosure [Text Block]

NOTE 13. VARIABLE INTEREST ENTITIES (“VIEs”)

In the second quarter of 2022, the Company completed a transition with respect to its relationship with its providers, transitioning to a structure whereby Talkspace LLC has entered into various agreements with a Texas professional association entity (Talkspace Provider Network, PA or “TPN”), which in turn contracts with our other affiliated professional entities ("PC entities"), physicians, therapists, and other licensed professionals for clinical and professional services provided to the Company's members. Talkspace LLC is party to various Management Services Agreements (“MSAs”) with TPN as well as the PC entities as part of this transition. The Company believes the transition to a structure where it operates under various MSAs with professional associations and professional corporations authorized by state law to contract with affiliated professionals to deliver teletherapy services to its members, helps ensure the Company is able to comply with all applicable regulatory requirements, including the corporate practice of medicine and fee-splitting laws, that are necessarily implicated by engaging in telehealth care that can only be delivered by physicians. The Company is continuing to transition its current agreements with its customers, members and other business partners to TPN or the PC entities, where applicable.

Pursuant to the MSAs, Talkspace LLC is the managing entity (the “Manager”) and provides management and administrative resources and services essential to the operations of TPN and the PC entities and receives a management fee for these services and reimbursement of expenses incurred. TPN and the PC entities in turn have the obligation under the MSAs to engage all licensed physicians and other health professionals to provide behavioral healthcare services to the Company's members. In addition, to the extent that TPN or the PC entities lack sufficient funds to meet their obligations, the Manager may, at its sole discretion, advance funds to TPN or the PC entities to cover these obligations. Such advances would be considered loans made by Manager and should be repaid as per the terms of the management agreement. No such advances have been made by the Manager to TPN or the PC entities as of December 31, 2024 and 2023.

The Company holds a variable interest in TPN and the PC entities. The Company evaluates whether an entity in which it has a variable interest is considered a VIE. VIEs are generally entities that have either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest (i.e., ability to direct the activities of the entity that most significantly impact the entity's economic performance through voting rights and a right to receive the expected residual returns of the entity or an obligation to absorb the expected losses of the entity).

Under the provisions of ASC 810, “Consolidation”, an entity consolidates a VIE if it is determined to be the primary beneficiary of the VIE. The primary beneficiary has both (a) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance, and (b) the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.

The Company also determined that it is able to direct the activities of TPN and the PC entities that most significantly impact their economic performance and it funds and absorbs all losses of these VIEs resulting in the Company being the primary beneficiary of these entities. Accordingly, the Company consolidates these VIEs.


(in thousands)	December 31, 2024		December 31, 2023
ASSETS
Cash and cash equivalents	$	132	$	167
Accounts receivable		6,743		4,031
Other assets		20,986		11,493
Total Assets	$	27,861	$	15,691
LIABILITIES
Accrued expenses and other current liabilities		2,528		2,831
Total Liabilities	$	2,528	$	2,831

Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets, Net [Abstract]
Amortization of Intangible Assets	$ 0.4	$ 0.7	$ 0.9

Cover Page - USD ($) $ in Millions	12 Months Ended
Cover Page - USD ($) $ in Millions	Dec. 31, 2024	Mar. 10, 2025	Jun. 30, 2024
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Entity File Number	001-39314
Entity Registrant Name	TALKSPACE, INC.
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	84-4636604
Entity Address, Address Line One	622 Third Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
Entity Central Index Key	0001803901
City Area Code	212
Local Phone Number	284-7206
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Document Period End Date	Dec. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 326.2
Entity Common Stock, Shares Outstanding		168,437,252
Documents Incorporated By Reference Text Block	DOCUMENTS INCORPORATED BY REFERENCE Portions of the Company's definitive Proxy Statement for the 2025 Annual Meeting of Stockholders to be filed by the Company pursuant to Regulation 14A are incorporated by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the Company's fiscal year ended December 31, 2024.
Auditor Firm Id	1281
Auditor Name	Kost Forer Gabbay & Kasierer, a member of EY Global
Auditor Location	Tel-Aviv, Israel
Auditor Opinion [Text Block]	Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Talkspace, Inc. (the Company) as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income (loss), stockholders' equity and cash flows for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework)and our report dated March 12, 2025 expressed an unqualified opinion thereon.
Common Stock
Document Information [Line Items]
Security12b Title	Common stock, par value $0.0001 per share
Trading Symbol	TALK
Security Exchange Name	NASDAQ
Warrant
Document Information [Line Items]
Security12b Title	Warrants to purchase common stock
Trading Symbol	TALKW
Security Exchange Name	NASDAQ

Variable Interest Entities (Additional Information) (Detail)	12 Months Ended
	Dec. 31, 2024
Recourse [Member]
Variable Interest Entity [Line Items]
Variable Interest Entity, Financial or Other Support, Reasons	The Company holds a variable interest in TPN and the PC entities. The Company evaluates whether an entity in which it has a variable interest is considered a VIE. VIEs are generally entities that have either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest (i.e., ability to direct the activities of the entity that most significantly impact the entity's economic performance through voting rights and a right to receive the expected residual returns of the entity or an obligation to absorb the expected losses of the entity).

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Summary of Significant Accounting Policies and Estimates

12 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies and Estimates

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ESTIMATES

Basis of Presentation

The consolidated financial statements and accompanying notes have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the periods presented.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the consolidated financial statements. The Company’s significant estimates and assumptions used in these consolidated financial statements include, but are not limited to, the recognition of revenue, stock-based compensation awards and internal-use software costs. The Company bases its estimates on historical factors, current circumstances and the experience and judgment of management. The Company evaluates its assumptions on an ongoing basis. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based on information available at the time they are made. Estimates, by their nature, are based on judgment and available information, therefore, actual results could be materially different from these estimates.

Consolidation

The Company consolidates all subsidiaries in which it has a controlling financial interest, as well as any VIEs where the Company is deemed to be the primary beneficiary. Intercompany transactions and balances have been eliminated in the preparation of the consolidated financial statements.

Operating Segments

Talkspace provides virtual behavioral healthcare services through its online platform for one-on-one therapy delivered via messaging, audio and video. The Company's the chief operating decision maker (“CODM”) is the Chief Executive Officer, who manages the Company by reviewing consolidated results. Accordingly, the Company operates as one operating and reportable segment.

The CODM uses the Company’s consolidated net income (loss) to assess the financial performance of the Company and allocate resources. Since the Company operates in one operating segment, financial information, including consolidated net income (loss) information evaluated by the CODM can be found in the consolidated statements of income. Other financial information regarding the Company's operating segment is presented elsewhere in the consolidated financial statements.

The Company's assets are managed on a consolidated basis. For total asset information please refer to the consolidated balance sheets included within the consolidated financial statements. Most of the Company's long-lived tangible assets, as well as the Company's operating lease right-of-use asset are located in the United States with an immaterial portion located in Israel.

For the years ended December 31, 2024, 2023 and 2022, all of the Company’s revenues were generated from customers located in the United States. For the types of services from which the reportable segment derives its revenues please refer to Note 3, “Revenue Recognition”.

Stock Repurchases

The Company repurchases its common stock from time to time pursuant to a board-authorized share repurchase program. Stock repurchases are accounted under ASC 505-30, Treasury Stock. The Company's policy is to retire all stock repurchased immediately after the transaction is completed. The Company records the amounts repurchased in excess of par value as a reduction to additional paid in capital. See Note 9, “Capital Stock,” for further details.

Financial Statements in U.S. Dollars

The majority of the Company’s operations are based in the United States. Most of the Company’s revenues and costs are denominated in United States dollars (“dollar”). The Company’s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company’s functional and reporting currency.

Accordingly, non-dollar denominated transactions and balances have been re-measured into the functional currency in accordance with ASC 830, “Foreign Currency Matters”. These transactions were not material for the years ended December 31, 2024, 2023 and 2022.

Cash and Cash Equivalents

Cash equivalents are short-term, highly liquid investments that are readily convertible to cash, with original maturities of three months or less at the date acquired. The Company’s cash and cash equivalents generally consist of bank deposits and investments in money market funds, U.S. treasury securities and commercial paper.

The Company’s cash and cash equivalents are invested in major banks in the United States. Generally, these cash and cash equivalents and deposits may be redeemed upon demand. The Company deposits may exceed federally insured limits, however management believes that the financial institutions that hold the Company’s and its subsidiaries’ cash and cash equivalents are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these assets.

Marketable Securities

The Company invests excess cash primarily in U.S. treasury securities, U.S. government securities, corporate debt securities, certificates of deposit and commercial paper. These investments represent investments of cash which are available to support current operations as such the Company classifies all marketable securities that have effective maturities of three months or less from the date of purchase as cash equivalents and those with effective maturities of greater than three months, including highly liquid securities with maturities beyond twelve months, as marketable securities within current assets on the consolidated balance sheets. As the Company may sell these investments prior to their effective maturities, these investments are classified and accounted for as available for sale securities. The Company determines the appropriate classification of these investments at the time of purchase and reevaluates such designation at each balance sheet date.

The Company carries these at fair value and determines any realized gains or losses on the sale of these investments on a specific identification method, and includes such gains or losses in financial income, net, in the consolidated statements of income. Unrealized gains and losses are excluded from earnings and reported as a component of other comprehensive income (loss).

On each reporting period, the Company evaluates whether declines in fair value below carrying value are due to expected credit losses, as well as the ability and intent to hold the investment until a forecasted recovery occurs, in accordance with ASC 326. Allowance for credit losses on available for sale debt securities are recognized as a charge in financial income, net, in the consolidated statements of income. See Note 5, “Fair Value Measurements,” for further details.

Fixed Assets, net

The following table presents the average useful life used for the Company's fixed assets:


	Average Useful Life (years)
Computers and software		3
Furniture and equipment		5

Fixed assets are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the average useful lives of the assets.

Internal-use Software

The Company capitalizes costs related to software acquired, developed, or modified solely to meet its internal requirements with no substantive plans to market such software at the time of development. In accordance with ASC 350-40, Internal Use Software, software development activities generally consist of three stages (i) the preliminary project stage, (ii) the application development stage, and (iii) the post-implementation operational stage. Costs incurred during the preliminary project stage and during the post-implementation operational stage are expensed as incurred. Eligible costs incurred during the application development stage of the project are capitalized and are amortized on a straight-line basis over the software’s estimated useful life, generally 3 years. Maintenance costs are expensed as incurred. Capitalized costs include employee-related costs, inclusive of non-cash stock compensation expense for employees who are directly associated with and who devote time to software projects. See Note 6, “Fixed Assets, net,” for further details.

Leases

The Company accounts for its leases in accordance with ASC 842, “Leases”. The right-of-use (“ROU”) asset represents the Company’s right to use an underlying asset for the lease term and the lease liability represents an obligation to make payments based on the present value of lease payments over the lease term. The Company uses incremental borrowing rates based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The lease term includes options to extend or terminate the lease when it is reasonably certain these will be exercised.

The Company has elected not to record operating lease ROU assets and lease liabilities for leases with an initial term of 12 months or less. The Company also elected the practical expedient to not separate lease and non-lease components for its leases. The Company's lease assets and liabilities were immaterial as of December 31, 2024 and 2023. The Company's ROU lease asset is included within other long-term assets and the related lease liability is included within other long-term liabilities on the consolidated balance sheets.

Intangible Assets

Acquired identifiable finite-lived intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets. The basis of amortization approximates the pattern in which the assets are utilized, over their estimated useful lives. The Company routinely reviews the remaining estimated useful lives of finite-lived intangible assets. The Company's intangible assets are included within other long-term assets on the consolidated balance sheets. See Note 4, “Intangible Assets, net” for further details.

Impairment of Long-Lived Assets and Intangible Assets subject to Amortization, including ROU Lease Asset

Fixed assets, internal-use software, intangible assets and ROU lease assets are reviewed for impairment in accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If indicators are present, management performs a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to the asset to its carrying amount. If the undiscounted cash flows used in the test for recoverability are less than the carrying amount of the asset, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. There were no impairment charges for the years ended December 31, 2024, 2023 or 2022.

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers”, when the Company satisfies its performance obligation to perform its defined contractual obligations to provide virtual behavioral healthcare services. Revenue is recognized in an amount that reflects the consideration that the Company will be entitled in exchange for the service rendered. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that is included in the transaction price. Variable consideration is included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

Through its platform, Talkspace serves:

•

Health insurance plans (commercial and government) and employee assistance programs (“Payor”) who offer their insured members access to our platform at in-network reimbursement rates,

•

Direct-to-Enterprise (“DTE”) comprised of enterprises who offer their enterprise members access to our platform while their enterprise is under an active contract with Talkspace, and

•

Individual subscribers (“Consumer”) who subscribe directly to our platform.

Payor

The Company contracts with health insurance plans and employee assistance programs to provide therapy and psychiatry services to their eligible members. Revenue is recognized at a point in time, as virtual therapy or psychiatry sessions are rendered. The transaction price is determined based on contracted rates and includes variable consideration in the form of implicit price concessions. The Company determines the total transaction price, including an estimate of variable consideration, at contract inception and reassesses this estimate at each reporting date. The Company estimates the amount of variable consideration that is included in the transaction price primarily based on actual historical collection experience for each Payor. Revenue is presented net of implicit price concessions. Contracts include annual evergreen clauses and generally may be terminated by either party typically upon a minimum 60-day advance notice.

DTE

The Company contracts with enterprises to provide access to the Company's therapist platform for their enterprise members, primarily based on a per-member-per-month (“PMPM”) or paid-per-use (“PPU”) basis or as a fixed monthly fee. To the extent the transaction price includes variable consideration, revenue is recognized using the variable consideration allocation exception, or, if the allocation exception is not met, the Company recognizes revenue ratably over the period based on estimates of the variable consideration to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequent resolved. The majority of the contracts typically range in length from one to three years and are generally non-cancelable during the initial contractual term.

Consumer

The Company also generates revenues from the sale of monthly, quarterly, bi-annual and annual membership subscriptions to the Company's therapy platform as well as supplementary a la carte offerings directly to individual consumers through a subscription plan. The Company recognizes consumer revenues ratably over the subscription period, beginning when therapy services commence. The Company recognizes revenues from supplementary a la carte offerings at a point in time, as virtual therapy sessions are rendered. Members may cancel their subscription at any time and will receive a pro-rata refund for the subscription price. The transaction price from member subscription revenue and supplementary a la carte offerings includes variable consideration in the form of refunds. Revenue is presented net of refunds. The Company estimates the refund liability for the variable consideration portion of the transaction price primarily based on historical experience. The refund liability is recorded within the “Accrued expenses and other current liabilities” line item in the consolidated balance sheets. The refund liability was immaterial as of December 31, 2024 and 2023.

See Note 3, “Revenue Recognition,” for further details.

Accounts Receivable, net

Accounts receivables are stated net of credit losses allowance. The Company’s methodology for estimating credit loss is based on historical collection experience, customer creditworthiness, current and future economic condition and market condition. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. Accounts receivables are written off after all reasonable means to collect the full amount have been exhausted. See Note 3, “Revenue Recognition,” for further details.

Deferred Revenue

The Company records deferred revenues when cash payments from customers are received in advance of the Company's performance obligations to provide services. As of December 31, 2024 and 2023, deferred revenue related mainly to Consumer subscriptions. The Company expects to satisfy the majority of its performance obligations associated with deferred revenue within one year or less. See Note 3, “Revenue Recognition,” for further details.

Contract Costs

The Company capitalizes incremental costs of obtaining a contract if these costs are determined to be recoverable. Capitalized contract costs are expensed over the life the contract. As of December 31, 2024 and 2023, capitalized contract costs were immaterial.

Stock-based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation - Stock Compensation”. Compensation costs for share-based awards are measured at the fair value on the grant date and recognized as expense using the straight-line method for service-based awards over the requisite service period. The Company recognizes forfeitures of awards as they occur.

The fair value of stock options is determined using the Black-Scholes-Merton option pricing model. The option-pricing model requires a number of assumptions, of which the most significant is the expected stock price volatility and the expected option term. Expected volatility is calculated based upon the Company's historical share price movements as well as similar traded companies’ historical share price movements as adequate historical experience is not available to provide a reasonable estimate based only on the Company's share price. Expected term is calculated based on the simplified method as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is calculated based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends. The fair value of restricted stock units is measured as the grant-date closing price of the Company’s common stock. See Note 10, “Stock-based Compensation,” for further details.

Advertising Costs

Advertising costs include third-party software subscription services, third-party independent research, participation in trade shows, brand messaging and costs of communications materials to generate greater awareness and utilization of our platform among Payor and DTE customers. Advertising costs are expensed as incurred and were $26.1 million, $25.2 million and $37.8 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Employee Benefit Plan

The Company has established a 401(k) plan that qualifies as a deferred compensation arrangement under Section 401 of the Internal Revenue Code. All U.S. employees over the age of 21 are eligible to participate in the plan. The Company contributes 100% of eligible employee’s elective deferral up to 4% of eligible earnings. The Company's matching contributions to participants’ accounts were immaterial for the years ended December 31, 2024, 2023 and 2022.

Fair Value of Financial Instruments

The Company applies ASC 820, “Fair Value Measurements and Disclosures”. Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. Accounting guidance for the fair value measurement establishes a framework for measuring fair value, establishes a fair value measurement hierarchy, and requires certain fair value measurement disclosures. The fair value hierarchy established by this accounting guidance prioritizes the inputs used in valuation techniques into the following three categories (highest to lowest priority):

Level 1: Quoted prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company's marketable securities are recorded at fair value and are generally classified within Level 1 or Level 2 of the fair value hierarchy using quoted market prices or quotes from market makers or broker-dealers. Marketable securities classified within Level 1 are valued based on quoted market prices in active markets and consist of money market funds and commercial paper. Level 2 marketable securities primarily consist of investment grade and high-yield corporate debt, U.S. Treasury securities, U.S. Government securities, certificates of deposit and commercial paper. Financial instruments classified as Level 2 are valued based on quoted market prices for similar assets of liabilities or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

In June 2021, the Company assumed and also issued Private Placement Warrants. Private Placement Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying consolidated balance sheets. The warrants were measured at fair value at inception and thereafter on a recurring, quarterly basis, with changes in fair value presented within financial income, net, in the consolidated statements of income. Private Placement Warrants are classified within Level 3 in the fair value hierarchy. These warrants were valued using the Black-Scholes-Merton Model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the implied volatility from trading prices of the Company's Public Warrants. Significant increases (decreases) in this input in isolation would have resulted in a significantly higher (lower) fair value measurement. See Note 5, “Fair Value Measurements,” for further details.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently enacted tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net earnings at that time. Accrued interest and penalties are included within the related tax asset or liability in the accompanying consolidated financial statements.

The Company follows the provisions in ASC 740 and the guidance related to accounting for uncertainty in income taxes. ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company's policy is to recognize interest related to unrecognized tax benefits as interest expense and penalties in income tax expense.

The Company does not provide deferred tax liabilities when it intends to reinvest earnings of a foreign subsidiary indefinitely or if distributed, no tax liability will be imposed. Undistributed earnings of a foreign subsidiary and unrecognized deferred tax liability related to such earnings are immaterial as of December 31, 2024 and 2023.

As of December 31, 2024 and 2023 the Company did not record any provision for uncertain tax positions. The Company does not anticipate that the assessment will significantly increase or decrease within the next 12 months. No accrued interest or penalties were accrued as of December 31, 2024 and 2023. See Note 12, “Income Tax Expense,” for further details.

Net Income (Loss) Per Share

The Company’s basic net income (loss) per share is calculated by dividing net income (loss) attributable to ordinary shareholders by the weighted-average number of shares of common stock outstanding for the period, without consideration of potentially dilutive securities. The diluted net income (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. Diluted net income (loss) per share is the same as basic net income (loss) per share in periods when the effects of potentially dilutive shares of shares of common stock are anti-dilutive. See Note 11, “Net Income (Loss) per Share,” for further details.

Recently Issued and Recently Adopted Accounting Pronouncements

The following Accounting Standards Updates (“ASU”) issued by the Financial Accounting Standards Board (“FASB”) have been adopted by the Company:

In November 2023, the FASB issued ASU 2023- 07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, to improve reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses. This ASU applies to all public entities, including those with a single reportable segment. The revised guidance will require disclosure of significant segment expenses that are regularly provided to the CODM, the title and position of the CODM and how the CODM uses the reported measures of segment profit or loss in assessing segment performance, among other requirements. This ASU is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted this ASU during the year ended December 31, 2024 on a retrospective basis.

Recently Issued Accounting Pronouncements Not yet Adopted

The following ASUs issued by the FASB have not yet been adopted by the Company:

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. This ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating ASU 2023-09 to determine the impact it may have on its consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement (Topic 220): Disaggregation of Income Statement Expenses, to improve the disclosures of a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. This guidance is effective for fiscal years beginning after December 15, 2026, and interim periods after December 15, 2027. The Company is currently evaluating ASU 2024-03 to determine the impact it may have on its consolidated financial statements and related disclosures.

Borrowing Arrangements - Additional Information (Detail) - $ / shares	Dec. 31, 2024	Dec. 31, 2023
Line Of Credit Facility [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 11.5	$ 11.5

STOCK-BASED COMPENSATION - Summary of Stock Option Activity Under 2021 Plan (Detail) (Parenthetical) - Employee Stock Option [Member]	12 Months Ended
	Dec. 31, 2024 shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares excluded from aggregate intrinsic value of options outstanding	2,766,728
Number of shares excluded from options exercisable aggregate intrinsic value	2,519,646

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 76,692	$ 123,908
Marketable securities	41,118	0
Accounts receivable, net	9,643	10,174
Other current assets	2,729	5,718
Total current assets	130,182	139,800
Other long-term assets	8,495	2,421
Total assets	138,677	142,221
CURRENT LIABILITIES:
Accounts payable	7,710	6,111
Deferred revenues	3,282	3,069
Accrued expenses and other current liabilities	8,031	12,468
Total current liabilities	19,023	21,648
Warrant liabilities	1,690	1,842
Other long-term liabilities	569	85
Total liabilities	21,282	23,575
Commitments and contingencies (note 7)
STOCKHOLDERS' EQUITY:
Common stock of $0.0001 par value - Authorized: 1,000,000,000 shares at December 31, 2024 and 2023; Issued and outstanding: 168,849,591 and 168,428,856 shares at December 31, 2024 and 2023, respectively	17	16
Additional paid-in capital	386,612	389,014
Accumulated deficit	(269,236)	(270,384)
Accumulated other comprehensive income	2	0
Total stockholders equity	117,395	118,646
Total liabilities and stockholders' equity	$ 138,677	$ 142,221

Summary of Significant Accounting Policies and Estimates (Policies)

12 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Financial Statements in U.S. Dollars

Cash and Cash Equivalents

Marketable Securities

Fixed Assets, net

The following table presents the average useful life used for the Company's fixed assets:


	Average Useful Life (years)
Computers and software		3
Furniture and equipment		5

Fixed assets are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the average useful lives of the assets.

Internal-use Software

Leases

Intangible Assets

Impairment of Long-Lived Assets and Intangible Assets subject to Amortization, including ROU Lease Asset

Revenue Recognition

Through its platform, Talkspace serves:

•

Health insurance plans (commercial and government) and employee assistance programs (“Payor”) who offer their insured members access to our platform at in-network reimbursement rates,

•

Direct-to-Enterprise (“DTE”) comprised of enterprises who offer their enterprise members access to our platform while their enterprise is under an active contract with Talkspace, and

•

Individual subscribers (“Consumer”) who subscribe directly to our platform.

Payor

DTE

Consumer

See Note 3, “Revenue Recognition,” for further details.

Accounts Receivable, net

Deferred Revenue

Contract Costs

Stock-based Compensation

Advertising Costs

Employee Benefit Plan

Fair Value of Financial Instruments

Level 1: Quoted prices in active markets for identical assets or liabilities.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Income Taxes

Net Income (Loss) Per Share

Recently Issued and Recently Adopted Accounting Pronouncements

The following Accounting Standards Updates (“ASU”) issued by the Financial Accounting Standards Board (“FASB”) have been adopted by the Company:

Recently Issued Accounting Pronouncements Not yet Adopted

The following ASUs issued by the FASB have not yet been adopted by the Company:

Fixed Assets, Net

12 Months Ended

Dec. 31, 2024

Fixed Assets Disclosure [Abstract]

FIXED ASSETS, NET

NOTE 6. FIXED ASSETS, NET

Fixed assets, net is included as part of other long-term assets in the consolidated balance sheets. Fixed assets, net as of December 31, 2024 and 2023 consisted of the following:


	December 31, 2024			December 31, 2023
(in thousands)
Capitalized internal-use software costs	$	6,488		$	431
Computers and equipment		755			736
Other		139			35
Total cost		7,382			1,202
Less: accumulated depreciation		(1,123	)		(888	)
Fixed assets, net	$	6,259		$	314

Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Revenues	$ 187,593	$ 150,045	$ 119,567
Cost of revenues	101,757	75,665	59,229
Gross profit	85,836	74,380	60,338
Operating expenses:
Research and development, net	10,510	17,571	21,659
Clinical operations, net	6,542	6,159	6,591
Sales and marketing	50,654	52,544	72,842
General and administrative	22,627	21,315	36,270
Impairment of goodwill	0	0	6,134
Total operating expenses	90,333	97,589	143,496
Operating loss	(4,497)	(23,209)	(83,158)
Financial (income), net	(5,739)	(4,245)	(3,740)
Income (loss) before income taxes	1,242	(18,964)	(79,418)
Income tax expense	94	218	254
Net loss	$ 1,148	$ (19,182)	$ (79,672)
Net loss per share:
Earnings Per Share, Basic	$ 0.01	$ (0.12)	$ (0.51)
Earnings Per Share, Diluted	$ 0.01	$ (0.12)	$ (0.51)
Weighted average number of common shares used in computing basic net loss per share	168,906,900	165,039,920	156,885,256
Weighted average number of common shares used in computing diluted net loss per share	176,495,872	165,039,920	156,885,256

Fair Value Measurements - Additional Information (Detail) - $ / shares

12 Months Ended

Dec. 31, 2024

Dec. 31, 2023

Class of Warrant or Right, Exercise Price of Warrants or Rights

$ 11.5

Private Placement Warrant [Member]

Expected volatility

^[1]

68.80%

61.10%

Class of Warrant or Right, Outstanding

12,757,500

12,780,000

[1]	The expected volatility is based on the volatility implied by backsolving to the Public Warrants' price as of the valuation date.

Business Combination - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Common stock, par value	$ 0.0001	$ 0.0001
Preferred stock, par value	$ 0.0001
Repurchase of common stock for retirement	$ 11,003	$ 0	$ 0
Common stock, shares outstanding	168,849,591	168,428,856
Common stock, shares authorized	1,000,000,000	1,000,000,000
Preferred stock, shares authorized	100,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 11.5	$ 11.5
Warrant liabilities	$ 1,690	$ 1,842
Common Stock [Member]
Business Acquisition [Line Items]
Common stock, shares outstanding	168,849,591	168,428,856	161,155,030	152,862,447

INCOME TAX EXPENSE - Summary of Income Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S. operations	$ 1,078	$ (19,576)	$ (79,788)
Foreign operations	164	612	370
Income (loss) before income taxes	$ 1,242	$ (18,964)	$ (79,418)

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Summary of Significant Accounting Policies and Estimates (Tables)

12 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Schedule Of Depreciation Of Property Plant Equipment

The following table presents the average useful life used for the Company's fixed assets:


	Average Useful Life (years)
Computers and software		3
Furniture and equipment		5

Fair Value Measurements

12 Months Ended

Dec. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

NOTE 5. FAIR VALUE MEASUREMENTS

The carrying value of the Company’s cash, cash equivalents, accounts receivable, other current assets, accounts payable, and accrued liabilities approximate fair value because of the relatively short-term nature of the underlying assets or liabilities.

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 31, 2024 and December 31, 2023:


	Fair Value Measurements as of December 31, 2024
(in thousands)	Adjusted Cost Basis		Unrealized Gains		Unrealized Losses			Fair Value		Cash and Cash Equivalents		Marketable Securities
Cash	$	911	$	—	$	—		$	911	$	911	$	—
Level 1:
Money market funds		68,639		—		—			68,639		68,639		—
Commercial paper		6,876		3		—			6,879		648		6,231
Total level 1		75,515		3		—			75,518		69,287		6,231
Level 2:
U.S. Treasury securities		7,232		2		—			7,234		6,494		740
U.S. Government securities		1,439		2		—			1,441		—		1,441
Certificates of deposit		2,920		1		—			2,921		—		2,921
Corporate debt securities		29,791		7		(13	)		29,785		—		29,785
Total level 2		41,382		12		(13	)		41,381		6,494		34,887
	$	117,808	$	15	$	(13	)	$	117,810	$	76,692	$	41,118


	Fair Value Measurements as of December 31, 2023
(in thousands)	Adjusted Cost Basis		Unrealized Gains		Unrealized Losses			Fair Value		Cash and Cash Equivalents		Marketable Securities
Cash	$	1,078	$	—	$	—		$	1,078	$	1,078	$	—
Level 1:
Money market funds		122,830		—		—			122,830		122,830		—
	$	123,908	$	—	$	—		$	123,908	$	123,908	$	—

Contractual Maturities

The following table summarizes the remaining contractual maturities of our marketable securities as of December 31, 2024:


	As of December 31, 2024
(in thousands)	Fair Value
Due within one year	$	29,499
Due after one year through two years		11,619
Total	$	41,118

Level 3

The following table presents changes in Level 3 liabilities measured at fair value on a recurring basis for the years ended December 31, 2024 and 2023:


	Level 3 Liabilities
	Year Ended December 31, 2024
(in thousands)	Beginning Balance		Change in Fair Value			Ending Balance
Private Placement Warrants	$	1,842	$	(152	)	$	1,690

	Level 3 Liabilities
	Year Ended December 31, 2023
(in thousands)	Beginning Balance		Change in fair Value			Ending Balance
Private Placement Warrants	$	939	$	903		$	1,842

The following were the inputs utilized in determining the fair value of the Private Placement Warrants as of December 31, 2024 and 2023:


	Year Ended December 31,
	2024	2023
Dividend yield (1)	0%	0%
Expected volatility (2)	68.80%	61.10%
Risk-free interest rate (3)	4.20%	4.13%
Time to maturity (years)	1.47	2.47

(1) No dividends were paid for the years ending December 31, 2024 and 2023.

(2) The expected volatility is based on the volatility implied by backsolving to the Public Warrants' price as of the valuation date.

(3) The risk -free interest rate is based on the yield from U.S. Treasury bonds with an equivalent term to the time to maturity of the warrants.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 107
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 940
-SubTopic 820
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478119/940-820-50-1

+ Details

Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated other comprehensive income	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 192,273	$ 15	$ 363,788	$ 0	$ (171,530)
Beginning balance, shares at Dec. 31, 2021		152,862,447
Exercise of stock options	3,181	$ 1	3,180
Exercise of stock options, share		5,331,634
Restricted stock units vested, net of tax	(362)		(362)
Restricted stock units vested, net of tax, Share		2,960,949
Repurchase of common stock for retirement	0
Stock-based compensation	12,116		12,116
Net loss	(79,672)				(79,672)
Ending balance at Dec. 31, 2022	127,536	$ 16	378,722	0	(251,202)
Ending balance, shares at Dec. 31, 2022		161,155,030
Exercise of stock options	2,707		2,707
Exercise of stock options, share		4,592,195
Restricted stock units vested, net of tax	(810)		(810)
Restricted stock units vested, net of tax, Share		2,681,631
Repurchase of common stock for retirement	0
Stock-based compensation	8,395		8,395
Net loss	(19,182)				(19,182)
Ending balance at Dec. 31, 2023	$ 118,646	$ 16	389,014	0	(270,384)
Ending balance, shares at Dec. 31, 2023	168,428,856	168,428,856
Exercise of stock options	$ 2,010		2,010
Exercise of stock options, share	1,710,285	1,710,285
Restricted stock units vested, net of tax	$ (3,195)	$ 1	(3,196)
Restricted stock units vested, net of tax, Share		2,621,709
Repurchase of common stock for retirement	(11,003)		(11,003)
Repurchase of common stock for retirement, Share		(3,911,259)
Other comprehensive income	2			2
Stock-based compensation	9,787		9,787
Net loss	1,148				1,148
Ending balance at Dec. 31, 2024	$ 117,395	$ 17	$ 386,612	$ 2	$ (269,236)
Ending balance, shares at Dec. 31, 2024	168,849,591	168,849,591

Accrued Expenses and Other Current Liabilities - Schedule of Accrued expenses and other current liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Accrued Expense and Other Current Liabilities [Abstract]
Employee compensation	$ 5,144	$ 7,269
Professional fees	912	626
Severance	494	0
User acquisition	248	1,525
Other	1,233	3,048
Accrued expenses and other current liabilities	$ 8,031	$ 12,468

Net Loss Per Share

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Net Loss Per Share

NOTE 11. NET INCOME (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders for the years ended December 31, 2024, 2023 and 2022:


	Year Ended December 31,
(in thousands except share and per share data)	2024		2023			2022
Net income (loss)	$	1,148	$	(19,182	)	$	(79,672	)
Weighted-average shares used to compute net income (loss) per share:
Basic		168,906,900		165,039,920			156,885,256
Dilutive effect of share-based awards		7,588,972		—			—
Diluted		176,495,872		165,039,920			156,885,256
Net income (loss) per share:
Basic	$	0.01	$	(0.12	)	$	(0.51	)
Diluted	$	0.01	$	(0.12	)	$	(0.51	)

For the year ended December 31, 2024, the following were excluded from the calculation of diluted net income per share since each would have had an anti-dilutive effect: 437,694 stock options, 40,149 restricted stock units, 12,757,500 Private Placement Warrants and 20,722,500 Public Warrants to purchase the Company’s common stock.

For the year ended December 31, 2023, the following were excluded from the calculation of diluted loss per share since each would have had an anti-dilutive effect given the Company’s net loss: 11,208,573 stock options, 8,984,827 restricted stock units, 12,780,000 Private Placement Warrants and 20,700,000 Public Warrants to purchase the Company’s common stock.

For the year ended December 31, 2022, the following were excluded from the calculation of diluted loss per share since each would have had an anti-dilutive effect given the Company’s net loss: 17,526,326 stock options, 9,127,051 restricted stock units, 12,780,000 Private Placement Warrants and 20,700,000 Public Warrants to purchase the Company’s common stock.

Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue by Revenue Source


	Year Ended December 31,
	2024		2023		2022
(in thousands)
Payor	$	124,339	$	80,823	$	36,168
DTE		38,466		33,614	$	28,241
Consumer		24,788		35,608		55,158
Total	$	187,593	$	150,045	$	119,567

INCOME TAX EXPENSE - Summary Of Reconciliation Of Effective Tax Rate And Statutory Income Tax Rate (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Income (loss) before income taxes	$ 1,242	$ (18,964)	$ (79,418)
Statutory tax rate	21.00%	21.00%	21.00%
Federal taxes	$ 261	$ (3,982)	$ (16,678)
Increase (decrease) in effective tax rate due to:
State taxes, net of federal benefit	(164)	276	(4,079)
Impairment of goodwill	0	0	1,288
Permanent differences	683	897	83
Other Adjustments	(648)	(373)	(6,669)
Valuation Allowance	(38)	3,400	26,309
Total	$ 94	$ 218	$ 254

Commitments and Contingencies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Legal Fees	$ 0

NET INCOME (LOSS) PER SHARE - Additional Information (Detail) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	40,149	8,984,827	9,127,051
Private Placement Warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	12,757,500	12,780,000	12,780,000
Public Warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	20,722,500	20,700,000	20,700,000
Employee Stock Option
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	437,694	11,208,573	17,526,326

NET INCOME (LOSS) PER SHARE - Schedule of Computation of Basic and Diluted Net Income Loss Per Share Attributable to Common Stockholders (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Net loss	$ 1,148	$ (19,182)	$ (79,672)
Weighted-average shares used to compute net income (loss) per share:
Weighted average number of common shares used in computing basic net loss per share	168,906,900	165,039,920	156,885,256
Dilutive effect of share-based awards	7,588,972	0	0
Weighted average number of common shares used in computing diluted net loss per share	176,495,872	165,039,920	156,885,256
Net loss per share: Basic	$ 0.01	$ (0.12)	$ (0.51)
Net loss per share: Diluted	$ 0.01	$ (0.12)	$ (0.51)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Fair Value Measurements - Schedule of determining the fair value assumptions of the private placement warrants (Details)

12 Months Ended

Dec. 31, 2024

Dec. 31, 2023

Dec. 31, 2022

Class of Warrant or Right [Line Items]

Dividend yield

0.00%

Private Placement Warrant [Member]

Class of Warrant or Right [Line Items]

Dividend yield

^[1]

0.00%

Expected volatility

^[2]

68.80%

61.10%

Risk Free Interest Rate

^[3]

4.20%

4.13%

Time to maturity (years)

1 year 5 months 19 days

2 years 5 months 19 days

[1]	No dividends were paid for the years ending December 31, 2024 and 2023.
[2]	The expected volatility is based on the volatility implied by backsolving to the Public Warrants' price as of the valuation date.
[3]	The risk -free interest rate is based on the yield from U.S. Treasury bonds with an equivalent term to the time to maturity of the warrants.

Revenue Recognition - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Accounts Receivable, net	$ 9,643	$ 10,174
Deferred Revenue	2,000	2,800
Revenues	$ 27,600	$ 25,300
Customer Two [Member] \| Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Minimum [Member]
Disaggregation of Revenue [Line Items]
accounts receivable balance		10.00%	10.00%
Customer Three [Member] \| Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Minimum [Member]
Disaggregation of Revenue [Line Items]
accounts receivable balance	10.00%
DTE
Disaggregation of Revenue [Line Items]
Revenues			$ 22,700
DTE \| Accounts Receivable [Member]
Disaggregation of Revenue [Line Items]
Accounts Receivable, net	$ 6,000	$ 7,800
Payor
Disaggregation of Revenue [Line Items]
Accounts Receivable, net	$ 3,600	$ 2,400

STOCK-BASED COMPENSATION - Summary of Restricted Stock Units Activity (Detail)	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of options, Granted	1,013,381
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Nonvested at beginning of year	8,984,827
Number of options, Granted	3,142,300
Vested	(3,776,287)
Forfeited	(1,323,765)
Nonvested at end of year	7,027,075
Weighted average fair value, beginning balance \| $ / shares	$ 1.3
Weighted average grant date fair value, granted \| $ / shares	2.87
Weighted average grant date fair value, vested \| $ / shares	1.71
Weighted average grant date fair value, forfeited \| $ / shares	1.77
Weighted average fair value, ending balance \| $ / shares	$ 1.73

Capital Stock - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024	Aug. 01, 2024	Feb. 22, 2024	Dec. 31, 2023
Class Of Stock [Line Items]
Preferred stock, par value	$ 0.0001
Preferred Stock, Shares Authorized	100,000,000
Common stock, par value	$ 0.0001			$ 0.0001
Common Stock, Shares Authorized	1,000,000,000			1,000,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 11.5			$ 11.5
Share Repurchase Program [Member]
Class Of Stock [Line Items]
Stock Repurchase Program Authorized Amount	$ 29.0
Share Repurchase Program [Member] \| Common Stock
Class Of Stock [Line Items]
Common Stock Subject To Repurchase Or Cancellation Shares	3,911,259
Consideration Per Shares	$ 2.81
Share Repurchase Program [Member] \| Board Of Directors Chairman [Member]
Class Of Stock [Line Items]
Stock Repurchase Program Authorized Amount		$ 25.0	$ 15.0
Public Warrant [Member]
Class Of Stock [Line Items]
Class of Warrant or Right, Outstanding	20,722,500			20,700,000
Private Placement Warrants
Class Of Stock [Line Items]
Class of Warrant or Right, Outstanding	12,757,500			12,780,000

STOCK-BASED COMPENSATION - Summary of Stock Option Activity Under 2021 Plan (Detail) - USD ($)
$ / shares in Units, $ in Thousands

12 Months Ended

Dec. 31, 2024

Dec. 31, 2023

Share-Based Payment Arrangement, Disclosure [Abstract]

Number of options, Outstanding at the beginning of the period

11,208,571

Number of options, Granted

1,013,381

Exercise of stock options, share

(1,710,285)

Number of options, Forfeited

(786,572)

Number of options, Outstanding at the end of the period

9,725,095

11,208,571

Number of options, Exercisable at the end of the period

7,565,044

Weighted average exercise price, Outstanding at the beginning of the period

$ 2.77

Weighted average exercise price, Granted

2.51

Weighted average exercise price, Exercised

1.17

Weighted average exercise price, Forfeited

3.89

Weighted average exercise price, Outstanding at the end of the period

2.93

$ 2.77

Weighted average exercise price, Exercisable at the end of the period

$ 3.15

Weighted average remaining contractual term (in years)

6 years 4 months 20 days

6 years 10 months 28 days

Weighted average remaining contractual term (in years) Exercisable at the end of the period

5 years 10 months 9 days

Aggregate intrinsic value, Outstanding

^[1]

$ 12,974

$ 11,774

Aggregate intrinsic value, Exercisable at the end of the period

^[1]

$ 10,148

[1]	The aggregate intrinsic value of options outstanding and options exercisable at end of the year does not include 2,766,728 and 2,519,646, respectively, of stock options that are out of the money.

Fair Value Measurements - Summary of warrants (Detail) - Private Placement Warrants - Level 3 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Class Of Warrant Or Right [Line Items]
Fair value as of beginning	$ 1,842	$ 939
Change in value	(152)	903
Fair value as of ending	$ 1,690	$ 1,842

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2024

Class of Warrant or Right [Line Items]

Schedule of Determining the Fair Value Assumptions of Private Placement Warrants


	Year Ended December 31,
	2024	2023	2022
Dividend yield	0%	0%	0%
Expected volatility	60.81% - 61.65%	58.63% - 68.40%	66.80%-86.13%
Risk-free interest rate	3.71%-4.19%	3.70%-4.22%	1.76%-4.11%
Expected term (years)	5.27 - 6.11	5.23 - 6.25	5.07-6.25

Schedule of Assets and Liabilities, Recorded at Fair Value

The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of December 31, 2024 and December 31, 2023:


	Fair Value Measurements as of December 31, 2024
(in thousands)	Adjusted Cost Basis		Unrealized Gains		Unrealized Losses			Fair Value		Cash and Cash Equivalents		Marketable Securities
Cash	$	911	$	—	$	—		$	911	$	911	$	—
Level 1:
Money market funds		68,639		—		—			68,639		68,639		—
Commercial paper		6,876		3		—			6,879		648		6,231
Total level 1		75,515		3		—			75,518		69,287		6,231
Level 2:
U.S. Treasury securities		7,232		2		—			7,234		6,494		740
U.S. Government securities		1,439		2		—			1,441		—		1,441
Certificates of deposit		2,920		1		—			2,921		—		2,921
Corporate debt securities		29,791		7		(13	)		29,785		—		29,785
Total level 2		41,382		12		(13	)		41,381		6,494		34,887
	$	117,808	$	15	$	(13	)	$	117,810	$	76,692	$	41,118


	Fair Value Measurements as of December 31, 2023
(in thousands)	Adjusted Cost Basis		Unrealized Gains		Unrealized Losses			Fair Value		Cash and Cash Equivalents		Marketable Securities
Cash	$	1,078	$	—	$	—		$	1,078	$	1,078	$	—
Level 1:
Money market funds		122,830		—		—			122,830		122,830		—
	$	123,908	$	—	$	—		$	123,908	$	123,908	$	—

Summary of the remaining contractual maturities of our cash equivalents and marketable securities

The following table summarizes the remaining contractual maturities of our marketable securities as of December 31, 2024:


	As of December 31, 2024
(in thousands)	Fair Value
Due within one year	$	29,499
Due after one year through two years		11,619
Total	$	41,118

Private Placement Warrant [Member]

Class of Warrant or Right [Line Items]

Summary of Warrants

The following table presents changes in Level 3 liabilities measured at fair value on a recurring basis for the years ended December 31, 2024 and 2023:


	Level 3 Liabilities
	Year Ended December 31, 2024
(in thousands)	Beginning Balance		Change in Fair Value			Ending Balance
Private Placement Warrants	$	1,842	$	(152	)	$	1,690

	Level 3 Liabilities
	Year Ended December 31, 2023
(in thousands)	Beginning Balance		Change in fair Value			Ending Balance
Private Placement Warrants	$	939	$	903		$	1,842

The following were the inputs utilized in determining the fair value of the Private Placement Warrants as of December 31, 2024 and 2023:


	Year Ended December 31,
	2024	2023
Dividend yield (1)	0%	0%
Expected volatility (2)	68.80%	61.10%
Risk-free interest rate (3)	4.20%	4.13%
Time to maturity (years)	1.47	2.47

(1) No dividends were paid for the years ending December 31, 2024 and 2023.

(2) The expected volatility is based on the volatility implied by backsolving to the Public Warrants' price as of the valuation date.

(3) The risk -free interest rate is based on the yield from U.S. Treasury bonds with an equivalent term to the time to maturity of the warrants.

STOCK-BASED COMPENSATION - Summary of Fair Value of Option Granted Using Black-Scholes-Merton Option Pricing Model with Assumptions (Detail)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Dividend yield	0.00%	0.00%	0.00%
Expected volatility rate, minimum	60.81%	58.63%	66.80%
Expected volatility rate, maximum	61.65%	68.40%	86.13%
Risk free interest rate, minimum	3.71%	3.70%	1.76%
Risk free interest rate, maximum	4.19%	4.22%	4.11%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (years)	5 years 3 months 7 days	5 years 2 months 23 days	5 years 25 days
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (years)	6 years 1 month 9 days	6 years 3 months	6 years 3 months

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net Income (Loss)	$ 1,148	$ (19,182)	$ (79,672)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	859	1,196	1,357
Stock-based compensation	9,173	8,395	12,116
Remeasurement of warrant liabilities	(152)	903	(3,131)
Impairment of goodwill	0	0	6,134
Decrease (increase) in accounts receivable	531	(534)	(4,126)
Decrease (increase) in other current assets	2,989	(1,346)	5,080
Increase (decrease) in accounts payable	1,599	(350)	(968)
Increase (decrease) in deferred revenues	213	(1,286)	(2,831)
(Decrease) increase in accrued expenses and other current liabilities	(4,437)	(4,034)	4,862
Other	(219)	(155)	102
Net cash provided by (used in) operating activities	11,704	(16,393)	(61,077)
Cash flows from investing activities:
Purchases of marketable securities	(41,118)	0	0
Capitalized internal-use software costs	(5,443)	0	0
Other	(171)	(141)	(317)
Net cash used in investing activities	(46,732)	(141)	(317)
Cash flows from financing activities:
Proceeds from exercise of stock options	2,010	2,707	3,181
Payments for employee taxes withheld related to vested stock-based awards	(3,195)	(810)	(853)
Repurchase of common stock for retirement	(11,003)	0	0
Payments from reverse capitalization	0	0	(645)
Net cash (used in) provided by financing activities	(12,188)	1,897	1,683
Net decrease in cash and cash equivalents	(47,216)	(14,637)	(59,711)
Cash and cash equivalents at the beginning of the year	123,908	138,545	198,256
Cash and cash equivalents at the end of the year	76,692	123,908	138,545
Supplemental cash flow data:
Cash paid during the year for interest	0	0	68
Cash paid during the year for income taxes	96	219	122
Non-cash investing activity:
Lease liabilities arising from obtaining right-of-use assets	595	0	466
Non-cash stock-based compensation capitalized in internal-use software costs	$ 614	$ 0	$ 0

Fixed Assets, Net - Schedule Of Fixed assets as part of other long-term assets (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Total cost	$ 7,382	$ 1,202
Less accumulated depreciation	(1,123)	(888)
Fixed assets, net	6,259	314
Capitalized internal-use software costs
Total cost	6,488	431
Computers and equipment
Total cost	755	736
Other
Total cost	$ 139	$ 35